Executive Oversight.

Leaders who know better, act better.

"Having access to Rivia, I feel like our team has been put in the driver's seat... they can easily look at data and graph it in a few clicks."

Chris Farina,

CEO Abcentra Therapeutics

For Clinical Operations and Trial Managers

Real-Time Trial Performance

Access a unified, real-time view of trial progress, including enrollment, safety monitoring, and protocol adherence. Measure against plan, forecasts, and budgets.

Pipeline Decision Support

Use data-driven insights to guide long-term pipeline and investment decisions with confidence.

Stakeholder Reporting

Present persuasive and nuanced interim readouts to your Board, investors, KOLs, and other stakeholders, reducing risk and improving impact.

Scalability and Cross-Program Insights

Store and analyze multiple trials in one platform to detect exploratory signals, uncover opportunities, and mitigate risks early.

Value

Optimized Pipeline Strategy

Reduce risk and maximize trial outcomes by prioritizing the right trials and refining TPP early.

Enhanced Oversight

Maintain comprehensive visibility into trial performance for better predictability and control.

Accelerated Strategic Decisions

Act 60% faster with data-ready insights for KOLs, investors, and stakeholders.

Multiple sources.

One verdict.

Rivia streamlines our decision-making process by providing visualizations that can be easily understood by key stakeholders like the board. This aids in rapid response and adjustments in our strategic approach.

Blanky Tu

Head of Clinical Operations Oncology, Alentis Therapeutics

"I think every medic in the clinical trial, and also clinical leads in trials, should use this kind of software to have a better overview of their data."

Jos G.A. Houbiers

Chief Medical Officer, Calypso Biotech

"Without Rivia, we would be very dependent on our CRO and biostatisticians for almost every little detail of what we're analyzing, and we'd be spending a lot of time merging Excel spreadsheets."

Chris Farina

CEO, Abcentra Therapeutics

Explore How Rivia Solves

Real-World Challenges